Latest Breaking News On - Heron therapeutics - Page 11 : comparemela.com

Heron Therapeutics rises on securing label expansion for pain therapy (NASDAQ:HRTX)

Heron Therapeutics rises on securing label expansion for pain therapy (NASDAQ:HRTX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Drug administrationHeron therapeuticsVial access needle

Heron Therapeutics Shares Rise 15% After FDA Approves Expanded Use of Zynrelef

By Chris Wack Heron Therapeutics shares were up 15% to $2.53 after the U.S. Food and Drug Administration approved its supplemental new drug application for.

Chris wackDrug administrationArticle normalDermatological treatmentsHealthcare life sciencesSpecialized drugs medicationsRegulation government policyNew products servicesProduct service approvalsCorporate industrial newsProducts servicesEquity marketsCommodity financial market newsContent typesFactiva filtersC amp ampe exclusion filter

Upcoming FDA Decision: Is Approval Likely for Heron Therapeutics ZYNRELEF SNDA?

Upcoming FDA Decision: Is Approval Likely for Heron Therapeutics ZYNRELEF SNDA?
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Edgar torresCrosslink life sciencesHeron therapeutics incHeron therapeuticsSupplemental new drug applicationBiotech beastBuy rating

Heron Therapeutics, Inc (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company

Key Insights Institutions' substantial holdings in Heron Therapeutics implies that they have significant influence over.

Heron therapeutics incVanguard group incHeron therapeuticHeron therapeuticsRubric capital managementVanguard groupHeron therapeuticsNstitutional ownershipInstitutional investors

Jacob Asset Management of New York LLC Has $337,000 Stock Position in Heron Therapeutics, Inc (NASDAQ:HRTX)

Jacob Asset Management of New York LLC Has $337,000 Stock Position in Heron Therapeutics, Inc (NASDAQ:HRTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong kongNew yorkUnited statesWilliamp forbesJacob asset management of new yorkSecurities exchange commissionHong kong ltdNeedham companyHeron therapeutics incBridgefront capitalJacob asset managementHeron therapeuticsFree reportAsset managementKong ltdGate manager